Showing results (1511-1520 of 1,529) with videos related to
Sort By:
Pageof 153
Biorxiv : the Preprint Server for Biology|February 26, 2026
Immunoregulatory gene GIMAP6 suppresses lethal atherosclerotic vasculopathy and ischemic heart failureChen Xiang, Kaja Arusha, Danielle Springer, et al.Bioorganic & Medicinal Chemistry Letters|January 5, 1999
3-Pyridyloxypropanolamine agonists of the beta 3 adrenergic receptor with improved pharmacokinetic propertiesA E Weber, H O Ok, R F Alvaro, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Novel Quinoline-Based P2-P4 Macrocyclic Derivatives As Pan-Genotypic HCV NS3/4a Protease InhibitorsUnmesh Shah, Charles Jayne, Samuel Chackalamannil, et al.JAMA|February 2, 2021
Association Between Dispatch of Mobile Stroke Units and Functional Outcomes Among Patients With Acute Ischemic Stroke in BerlinMartin Ebinger, Bob Siegerink, Alexander Kunz, et al.BMJ Open|October 31, 2023
Protocol of the Berlin Long-term Observation of Vascular Events (BeLOVE): a prospective cohort study with deep phenotyping and long-term follow up of cardiovascular high-risk patientsJoachim E Weber, Michael Ahmadi, Leif-Hendrik Boldt, et al.Paleoceanography and Paleoclimatology|October 17, 2022
Episodes of Early Pleistocene West Antarctic Ice Sheet Retreat Recorded by Iceberg Alley SedimentsIan Bailey, Sidney Hemming, Brendan T Reilly, et al.Journal of Medicinal Chemistry|December 29, 2015
Discovery of Vibegron: A Potent and Selective β3 Adrenergic Receptor Agonist for the Treatment of Overactive BladderScott D Edmondson, Cheng Zhu, Nam Fung Kar, et al.Nature Communications|October 2, 2022
Ancient marine sediment DNA reveals diatom transition in AntarcticaLinda Armbrecht, Michael E Weber, Maureen E Raymo, et al.Health and Quality of Life Outcomes|August 15, 2024
Converting PROMIS®-29 v2.0 profile data to SF-36 physical and mental component summary scores in patients with cardiovascular disordersGregor Liegl, Felix H Fischer, Carl N Martin, et al.Cell Reports. Medicine|November 20, 2024
Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancerCarsten Denkert, Andreas Schneeweiss, Julia Rey, et al.Pageof 153